{"id":"https://openalex.org/W2052018231","doi":"https://doi.org/10.1007/s002280000136","title":"The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide","display_name":"The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide","publication_year":2000,"publication_date":"2000-07-19","ids":{"openalex":"https://openalex.org/W2052018231","doi":"https://doi.org/10.1007/s002280000136","mag":"2052018231","pmid":"https://pubmed.ncbi.nlm.nih.gov/10954349"},"language":"en","primary_location":{"id":"doi:10.1007/s002280000136","doi":"https://doi.org/10.1007/s002280000136","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002280000136","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005047248","display_name":"Mitsutaka Takada","orcid":"https://orcid.org/0000-0003-0834-1005","observed_orcids":["https://orcid.org/0000-0003-0834-1005"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Takada","raw_affiliation_strings":["Department of Pharmacy, National Cardiovascular Center, Suita-city, Osaka, Japan. takadam@ncvc.hosp.go.jp","Department of Pharmacy, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan e-mail: takadam@ncvc.hosp.go.jp Tel.: +81-6-68335012; Fax: +81-6-68339865, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, National Cardiovascular Center, Suita-city, Osaka, Japan. takadam@ncvc.hosp.go.jp","institution_ids":["https://openalex.org/I4210111404"]},{"raw_affiliation_string":"Department of Pharmacy, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan e-mail: takadam@ncvc.hosp.go.jp Tel.: +81-6-68335012; Fax: +81-6-68339865, , JP","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Fujita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Fujita","raw_affiliation_strings":["Laboratory of Clinical Chemistry, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Chemistry, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079842025","display_name":"Yoshiaki Katayama","orcid":"https://orcid.org/0000-0003-1683-2154","observed_orcids":["https://orcid.org/0000-0003-1683-2154"]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Katayama","raw_affiliation_strings":["Laboratory of Clinical Chemistry, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Chemistry, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113629064","display_name":"Y. Harano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Harano","raw_affiliation_strings":["Division of Atherosclerosis, Metabolism, and Clinical Nutrition, Department of Medicine, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Atherosclerosis, Metabolism, and Clinical Nutrition, Department of Medicine, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan, , JP","institution_ids":["https://openalex.org/I4210111404"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087601112","display_name":"Masahiko Shibakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111404","display_name":"National Cerebral and Cardiovascular Center","ror":"https://ror.org/01v55qb38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210111404"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Shibakawa","raw_affiliation_strings":["Department of Pharmacy, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan e-mail: takadam@ncvc.hosp.go.jp Tel.: +81-6-68335012; Fax: +81-6-68339865, , JP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita-city, Osaka 565-0873, Japan e-mail: takadam@ncvc.hosp.go.jp Tel.: +81-6-68335012; Fax: +81-6-68339865, , JP","institution_ids":["https://openalex.org/I4210111404"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210111404"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":null,"fwci":0.4208,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.64670735,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"56","issue":"4","first_page":"335","last_page":"342"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.23690000176429749,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.23690000176429749,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.12389999628067017,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cibenzoline","display_name":"cibenzoline","score":0.9750000238418579},{"id":"https://openalex.org/keywords/disopyramide","display_name":"disopyramide","score":1.0},{"id":"https://openalex.org/keywords/drug-induced-hypoglycemia","display_name":"drug-induced hypoglycemia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.6259999871253967},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8939999938011169},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9589999914169312},{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.9850000143051147},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.800000011920929},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.753000020980835},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C2779831137","wikidata":"https://www.wikidata.org/wiki/Q425120","display_name":"Disopyramide","level":2,"score":0.942804753780365},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6287536025047302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5233542323112488},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3563825488090515},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3342530131340027},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.11796778440475464}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004206","descriptor_name":"Disopyramide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026902","descriptor_name":"Potassium Channel Blockers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s002280000136","doi":"https://doi.org/10.1007/s002280000136","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002280000136","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:10954349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10954349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W157477409","https://openalex.org/W200260629","https://openalex.org/W327342966","https://openalex.org/W1578681606","https://openalex.org/W1659950000","https://openalex.org/W1972618547","https://openalex.org/W1976347558","https://openalex.org/W1984679638","https://openalex.org/W1988661239","https://openalex.org/W1989799808","https://openalex.org/W1990421974","https://openalex.org/W1993592150","https://openalex.org/W2000101702","https://openalex.org/W2004005771","https://openalex.org/W2008197125","https://openalex.org/W2008658916","https://openalex.org/W2016898556","https://openalex.org/W2024118414","https://openalex.org/W2034337597","https://openalex.org/W2043617278","https://openalex.org/W2061068481","https://openalex.org/W2063312070","https://openalex.org/W2072695705","https://openalex.org/W2095369117","https://openalex.org/W2109591061","https://openalex.org/W2145796003","https://openalex.org/W2146894153","https://openalex.org/W2151678583","https://openalex.org/W2164966513","https://openalex.org/W2416467936"],"related_works":["https://openalex.org/W2322483339","https://openalex.org/W327342966","https://openalex.org/W2308854904","https://openalex.org/W2420381220","https://openalex.org/W2483215887","https://openalex.org/W41092492","https://openalex.org/W2416467936","https://openalex.org/W97782647","https://openalex.org/W2082918371","https://openalex.org/W2412771766"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}